Dose Response of Pursed Lip Breathing With Diaphragmatic Breathing On Pulmonary Functions in Patients With COPD

NCT04928729 | Completed DMC

• 1 other identifier: REC/00879 Tayyaba Kanwal
• Study Type: interventional
• Target: 54
• Locations: 1 country
• Sites: 1

Brief Summary

1. 1.To determine the Effects of combined pursed lip breathing with diaphragmatic breathing on pulmonary functions in patient with COPD.
2. 2.To determine the different durations of combined pursed lip breathing with diaphragmatic breathing on Pulmonary functions in patient with COPD.
3. 3.To determine the Effects of combined pursed lip breathing with diaphragmatic breathing on quality of life in patient with COPD

Conditions

COPD

Outcome Measures

Primary Outcomes (6)

• COPD Assessment Test (CAT)

  The COPD Assessment Test (CAT) is a questionnaire for patients with chronic obstructive pulmonary disease (COPD), which can be filled in to quantify their symptoms in the form of scores (0-40). Changes From the Baseline will be Assessed. It is categorized into four groups, that are, low(1) , medium(2), high(3) and very high(4) based on the level of effect of the disease on status of health.

  6th week

• Forced Expiratory Volume in 1 second (FEV1)

  Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters

  6th week

• Forced vital Capacity (FVC)

  Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters.

  6th Week

• Peak Expiratory Flow (PEF)

  Changes from the Baseline, the digital spirometer is used in clinical setting to analyze peak expiratory flow PEF in Liter/second.

  6th Week

• 6 min walk test: Distance (meters)

  Changes from the baseline, 6 min walk test was used to measure Functional capacity. It is a sub maximal exercise test which can aid in assessing functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters which an individual covers in 6 min without any support.

  6th week

• Modified Borg Scale of Perceived Exertion

  Changes from the Baseline, It is a subjective numeric scale ranging from 0 to 10, where 0 indicates "no dyspnea" and 10 indicates "unbearable dyspnea." A number is chosen by the patient in order to decide the best score that matches his level of dyspnea during physical activity.

  6th week

Study Arms (3)

Pursed Lip Breathing

EXPERIMENTAL

Other: Pursed Lip Breathing

Pursed Lip Breathing +DB

EXPERIMENTAL

Other: Pursed Lip Breathing +DB

Conservative care

EXPERIMENTAL

Other: Conservative care

Interventions

Pursed Lip Breathing OTHER

PLB with frequency of three times daily for First 3 days of week for a duration of 5-10 mins is perform.

Pursed Lip Breathing

Pursed Lip Breathing +DB OTHER

PLB+DB with frequency of three times daily for Last three days of week for a duration of 10-15 mins is perform.

Pursed Lip Breathing +DB

Conservative care OTHER

Participants will be having different dose as per tolerance 5 times daily.

Conservative care

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants were diagnosed as COPD
• The intervention PLB Combine with DB
• Stable COPD Patients (Mild and Moderate on GOLD criteria) Global Initiative for Chronic Obstructive Lung Disease (GOLD)

You may not qualify if:

• Patients with other Pulmonary diseases.
• cardiovascular, neurological and orthopedic diseases
• Obesity, history of recent exacerbation
• Uncontrolled arterial hypertension
• Any surgical complications
• Patients with ventilatory support

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Pulmonology Department of DHQ Teaching Hospital

Dera Ghazi Khan, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Muhammad Iqbal Tariq, MSCPPT

  Riphah International University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 14, 2021
• First Posted: June 16, 2021
• Study Start: October 15, 2020
• Primary Completion: September 30, 2021
• Study Completion: September 30, 2021
• Last Updated: October 20, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)